Commercialization Plans. Each Party shall submit a Commercialization Plan to the JSC for discussion no less [***] prior to the anticipated date of such Party obtaining Regulatory Approval for a Licensed Product. Thereafter, each Party shall provide a copy of the then-current Commercialization Plan to the JSC at least once each Calendar Year during the Licensed Product Royalty Term and Takeda Royalty Term, as applicable.
Appears in 4 contracts
Sources: Common Stock Purchase Agreement (Ultragenyx Pharmaceutical Inc.), License and Collaboration Agreement (Ultragenyx Pharmaceutical Inc.), License and Collaboration Agreement (Ultragenyx Pharmaceutical Inc.)